About CFL Pharmaceuticals Limited
Data last updated:
CFL Pharmaceuticals Limited is a public limited company based in Goa, India. It operates in the brokerage and trading services segment of the financial services sector. It was incorporated on 30 September 1981 and has been in existence for over 45 years.
The company is registered with the Registrar of Companies (ROC), Goa, under CIN U24246GA1981PLC000465. Its GSTIN is 24AAACC7387H1ZK (Gujarat). The company holds 9 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹75 Lakh. It was formerly known as Cosme Farma Laboratories Limited. It is led by directors including Maryann Veronica Menezes (Whole-Time Director) and Christine Stephanie Menezes (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dempo Towers 5th Floor Edc Patto Plaza Panjim, Goa, India – 403001.
As per the financials filed for FY 2025, the company reported a revenue of ₹201.84 Cr, a decline of 26% compared to the previous year. For the same year it recorded a net profit of ₹41.91 Cr (net margin 20.8%) and EBITDA of ₹48.27 Cr (EBITDA margin 23.9%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 26% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹128.83 Cr on record. Court records list 66 cases involving the company, including 34 filed by the company and 32 filed against it; 10 cases are pending. The company has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2013.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cflpharma.com.
Company details
CIN history
CFL Pharmaceuticals has one previous CIN (Corporate Identification Number): U24246GA1981PTC000465. The current CIN is U24246GA1981PLC000465, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24246GA1981PLC000465 | Current |
| U24246GA1981PTC000465 | Previous |
Contact details
CFL Pharmaceuticals Limited's registered office is in Goa. Its website is cflpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDempo Towers 5th Floor Edc Patto Plaza Panjim, Goa, India – 403001
- IndustryFinancial Services, Brokerage & Trading Services
To see the full contact details of CFL Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of CFL Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of CFL Pharmaceuticals Limited, buy the company report.
Financials of CFL Pharmaceuticals Limited
FY 2025 filings availableCFL Pharmaceuticals Limited reported revenue of ₹201.84 Cr (down 26% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 26% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹48.27 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.91 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | ||||
| Net Profit Margin | 20.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of CFL Pharmaceuticals Limited, buy the company report.
Board of directors of CFL Pharmaceuticals Limited
CFL Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Maryann Veronica Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Whole-Time Director | 30 Nov 2012 | 13 Years 11 Months | Current |
| Christine Stephanie Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Whole-Time Director | 10 Apr 2013 | 13 Years 6 Months | Current |
| Brenda Juliette Nazareth Menezes Also directs: Menezes Pharmaceuticals Limited, Frederick Electro Devices Private Limited, Cosme Bio-Tech Private Limited and 2 more | Director | 30 Oct 2013 | 13 Years 0 Months | Current |
Auditor
CFL Pharmaceuticals Limited is audited by M/S Shilpa Deshpande & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/S Shilpa Deshpande & Associates | FY 2023 | 119986W |
Shareholding
The shareholding of CFL Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of CFL Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2012 | 10357134 | Bank of India | ₹10.65 Cr | Satisfied | |
| 19 May 2009 | 10161178 | Bank of India | ₹10.65 Cr | Satisfied | |
| 11 Sep 2007 | 10070351 | Bank of India | ₹10.65 Cr | Satisfied | |
| 11 Sep 2007 | 10266570 | Bank of India | ₹30 Lakh | Satisfied | |
| 16 Mar 2005 | 90076512 | Bank of India | ₹18.36 Lakh | Satisfied |
To see the full charge records of CFL Pharmaceuticals Limited, buy the company report.
Total charge records: 25 View all charges
Deals & funding
CFL Pharmaceuticals Limited has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2013.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2013 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: an individual |
| Aug 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2012 | Acquisition | ₹507.83 Cr | Buyer: Adcock Ingram Holdings Ltd. Seller: CFL Pharmaceuticals Limited |
| May 2011 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 3 individuals |
| Apr 2007 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
CFL Pharmaceuticals Limited has 66 court cases on record: 34 filed by CFL Pharmaceuticals, 32 filed against it. 10 cases are pending and 56 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 38 | 22 | 6 |
| District courts | 27 | 9 | 4 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 66)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North Goa, Goa | Court case (MCA) | Filed by the company against M/S. Wallace Pharmaceuticals Pvt. Ltd. | Pending |
| District court, North Goa, Goa | Civil suit | Filed by the company against Wallace Pharmaceuticals Pvt. Ltd. | Pending |
| High Court | Court case (MCA) | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd., THR. Its Duly Aut. Rep., Eurico Noronha | Pending |
| High Court, GOA | Writ petition | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd., THR. Its Duly Aut. Rep., Eurico Noronha | Pending |
| High Court | Court case (MCA) | Filed against the company by Wallace Pharmaceuticals Pvt. Ltd., THR. Its Duly Aut. Rep., Eurico Noronha | Disposed |
To see the full case history of CFL Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for CFL Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
CFL Pharmaceuticals Limited has a workforce of 12 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
GST
CFL Pharmaceuticals has 9 GST registrations: 1 active and 8 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACC7387H1ZK | Gujarat | Active | 06 Nov 2018 |
To see the full GST registrations and return filing status of CFL Pharmaceuticals Limited, buy the company report.
Recent activity
CFL Pharmaceuticals Limited has 12 board changes on record since 2008: 3 appointments and 9 cessations. The latest: Andre Jose Joao De Menezes ceased to be Director on 28 Dec 2018.
67 earlier events are in the company report.
Frequently asked questions
CFL Pharmaceuticals is an active public limited company based in Goa, India. The company works in brokerage and trading services, within the financial services industry. It was incorporated on 30 September 1981 (45+ years old) and is registered under CIN U24246GA1981PLC000465.
CFL Pharmaceuticals has 3 current directors:
- Maryann Veronica Menezes - Whole-Time Director
- Christine Stephanie Menezes - Whole-Time Director
- Brenda Juliette Nazareth Menezes - Director
The latest financial statements of CFL Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of CFL Pharmaceuticals is 24AAACC7387H1ZK, registered in Gujarat. The company has 9 GST registrations in all, of which 1 is active and 8 are cancelled or inactive.
The CIN (Corporate Identification Number) of CFL Pharmaceuticals is U24246GA1981PLC000465. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
CFL Pharmaceuticals has 66 court cases on record: 34 filed by the company and 32 filed against it. 10 are pending. Most are in the high courts.
CFL Pharmaceuticals was incorporated on 30 September 1981, making it 45+ years old. It is registered with the Registrar of Companies, Goa.
CFL Pharmaceuticals has 5 deals on record (4 secondary share transfers, 1 acquisition); the latest was in September 2013.
Andre Jose Joao De Menezes ceased to be Director on 28 Dec 2018. Vishnu Gajanan Nagarsenkar ceased to be Director on 22 Aug 2016. Brenda Juliette Nazareth Menezes ceased to be Additional Director on 23 Sep 2014. CFL Pharmaceuticals has 12 board changes on record in total.
CFL Pharmaceuticals can be reached through the website cflpharma.com. Its registered office is in Goa, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
